Costar Group (CSGP): Notes From The Road - Needham
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Needham & Company analyst, Mayank Tandon, reiterated his Buy rating on shares of CoStar Group (NASDAQ: CSGP) following company sponsored management meetings. The analyst believes the company has a multi-billion-dollar market opportunity, high barriers to entry, and the potential for low double-digit organic revenue growth and sustained EBITDA margin expansion. He sees CoStar as a core holding name for growth-oriented investors.
Management reaffirmed their stated goal of hitting $1 billion in revenue in 2018 and exiting the year with 40% EBITDA margins even while continuing to invest to ensure their stronghold on the target market and the long-term growth of the business.
No change to the price target of $240.
Shares of CoStar Group closed at $216.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham & Company Cuts Price target Following Mobile Mini's (MINI) Weak 3Q
- Edwards Lifesciences (EW) PT Lowered to $114 at Stifel, 'Buy' Kept
- Needham & Company Starts AMAG Pharmaceuticals (AMAG) at Buy
Create E-mail Alert Related CategoriesAnalyst Comments
Related EntitiesNeedham & Company
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!